168.83
Irhythm Technologies Inc stock is traded at $168.83, with a volume of 493.36K.
It is down -0.16% in the last 24 hours and down -5.74% over the past month.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$169.10
Open:
$169
24h Volume:
493.36K
Relative Volume:
1.16
Market Cap:
$5.44B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-34.74
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
-5.35%
1M Performance:
-5.74%
6M Performance:
+16.05%
1Y Performance:
+91.57%
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Technologies Inc
|
168.83 | 5.45B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
Cim Investment Management Inc. Sells 5,929 Shares of iRhythm Technologies $IRTC - MarketBeat
Eventide Asset Management LLC Has $106.48 Million Stock Holdings in iRhythm Technologies $IRTC - MarketBeat
Natixis Purchases 17,500 Shares of iRhythm Technologies $IRTC - MarketBeat
WINTON GROUP Ltd Acquires Shares of 12,877 iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies $IRTC Shares Purchased by Next Century Growth Investors LLC - MarketBeat
Ophir Asset Management Pty Ltd Sells 175,598 Shares of iRhythm Technologies $IRTC - MarketBeat
(IRTC) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Jump Financial LLC Takes Position in iRhythm Technologies $IRTC - MarketBeat
From Hype to P&L: Hospitals Now Buying AI That Pays - GlobeNewswire
Does iRhythm Technologies (IRTC) Face a Governance Test That Could Reshape Its Innovation-Led Story? - Sahm
Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI) - TradingView
Aug PostEarnings: Can iRhythm Technologies Inc I25 stock attract analyst upgradesJuly 2025 PreEarnings & Entry and Exit Point Strategies - moha.gov.vn
Walleye Capital LLC Makes New Investment in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Nasdaq Index Data-Driven Health Solutions - Kalkine Media
HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLD - GuruFocus
HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
Quantbot Technologies LP Buys Shares of 23,242 iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Insider Chad Patterson Sells 280 Shares - MarketBeat
Insider Selling: iRhythm Technologies (NASDAQ:IRTC) Insider Sells 2,478 Shares of Stock - MarketBeat
Can iRhythm Technologies Inc. (I25) stock attract analyst upgradesMarket Volume Summary & Free Technical Pattern Based Buy Signals - Newser
Sands Capital Management LLC Sells 100,680 Shares of iRhythm Technologies $IRTC - MarketBeat
Is iRhythm Technologies Inc. (I25) stock a momentum leader2025 Big Picture & Free High Return Stock Watch Alerts - Newser
How iRhythm Technologies Inc. (I25) stock trades under stagflationMarket Trend Report & High Return Trade Guides - Newser
Will iRhythm Technologies Inc. (I25) stock benefit from Fed rate cuts2025 Biggest Moves & Stock Portfolio Risk Control - Newser
Why retail investors pile into iRhythm Technologies Inc. stock2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Can iRhythm Technologies Inc. (I25) stock test all time highsIPO Watch & Target Return Focused Picks - Newser
Is iRhythm Technologies Inc. (I25) stock ideal for retirement investorsJuly 2025 Review & Expert Approved Momentum Ideas - Newser
Insider Sell Alert: Chad Patterson Sells Shares of iRhythm Techn - GuruFocus
iRhythm Technologies Executives Sell Shares - TradingView
Officer Patterson Sells 280 ($51.8K) Of iRhythm Technologies Inc [IRTC] - TradingView
Officer Murphy Surrenders 2,478 Of iRhythm Technologies Inc [IRTC] - TradingView
IRTC: Strong growth in cardiac monitoring, proactive partnerships, and innovation drive future expansion - TradingView
Morgan Stanley Boosts iRhythm Technologies (NASDAQ:IRTC) Price Target to $205.00 - MarketBeat
New York State Common Retirement Fund Purchases 9,127 Shares of iRhythm Technologies $IRTC - MarketBeat
Schroder Investment Management Group Has $34.19 Million Stock Position in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference - Sahm
Can iRhythm Technologies Inc. (I25) stock sustain institutional flowsTrade Volume Report & Risk Adjusted Swing Trade Ideas - Newser
How iRhythm Technologies Inc. (I25) stock performs during market turbulenceJuly 2025 Intraday Action & AI Driven Stock Movement Reports - Newser
Morgan Stanley Maintains iRhythm Technologies (IRTC) Overweight Recommendation - MSN
iRhythm Technologies (IRTC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Does the Recent Device Approval Justify iRhythm Technologies' Surging Share Price in 2025? - Yahoo Finance
iRhythm Technologies (IRTC): Morgan Stanley Raises Price Target - GuruFocus
iRhythm Technologies (IRTC): Morgan Stanley Raises Price Target | IRTC Stock News - GuruFocus
How Global Study Results for Zio May Shape iRhythm Technologies' (IRTC) International Expansion Narrative - Yahoo Finance
Why iRhythm Technologies Inc. (I25) stock is listed among top recommendationsWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
How iRhythm Technologies Inc. (I25) stock performs in easing cyclesJuly 2025 Sector Moves & Fast Gain Stock Tips - Newser
Published on: 2025-12-02 02:34:48 - Newser
Why iRhythm Technologies Inc. (I25) stock stays undervalued2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Loomis Sayles & Co. L P Makes New $39.34 Million Investment in iRhythm Technologies $IRTC - MarketBeat
Mackenzie Financial Corp Reduces Stock Position in iRhythm Technologies $IRTC - MarketBeat
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):